VGM & ASSOCIATESHealthcare MSO
Full Menu Search

VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports

Published in Government Relations on October 09, 2025

VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. 

While we recognize the importance of strengthening domestic supply chains and safeguarding national security, VGM emphasized that any resulting trade restrictions must be carefully considered to avoid unintended harm to the durable medical equipment (DME) industry and the patients it serves. 

The submitted comments outlined below include several significant challenges that the DME industry could face if the investigation leads to increased trade restrictions: 

  1. Tariffs and Cost Increases. If new tariffs are imposed on imported medical equipment and components, manufacturers will experience immediate cost hikes. Many essential parts, used in products like wheelchairs, ventilators, and hospital beds, are sourced internationally due to cost and availability. These tariffs could raise production costs, reduce affordability, and limit access for patients and providers. 
  2. Supply Chain Disruption. The DME industry depends on a global supply chain to deliver timely and diverse products. Trade restrictions or tariffs could disrupt this system, causing delays, shortages, and uncertainty, especially critical items like prosthetics, insulin pumps, and glucose monitors that are vital to patient health. 
  3. Limited Domestic Manufacturing Capacity. While boosting domestic production is a worthy goal, current U.S. infrastructure cannot quickly scale to meet demand across all DME categories. Moving away from foreign suppliers without viable domestic alternatives could lead to service gaps. Any shift must consider realistic timelines, investment needs, and workforce readiness. 
  4. Impact on Patient Care and Providers. Higher costs and reduced access to DME products will directly affect patient outcomes. Providers may have to cut services, delay treatments, or pass costs onto patients, undermining healthcare resilience and compromising care quality. 
  5. Risk of Unintended Consequences. Efforts to reduce foreign dependency must be carefully tailored. Broad, one-size-fits-all policies could unintentionally harm U.S. manufacturers who rely on global inputs, stifle innovation, and reduce competitiveness. 

VGM urges the Department of Commerce to take a balanced, collaborative approach that protects national interests without compromising patient care or destabilizing the DME industry. We encourage policymakers to engage with stakeholders across the healthcare continuum to ensure that any future policies support both supply chain resilience and the continued delivery of high-quality, affordable medical equipment to those who need it most.

To submit comments and review the full Section 232 National Security Investigation notice, go to the Federal Rulemaking Portal. 

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

VGM Government Relations Launches State Payer Resource Hub for DMEPOS Providers thumbnail VGM Government Relations Launches State Payer Resource Hub for DMEPOS Providers This resource brings together key information frequently used by DMEPOS providers. Kentucky Governor Announces Reprieve from Previously Announced Kentucky Medicaid 4% Rate Cut thumbnail Kentucky Governor Announces Reprieve from Previously Announced Kentucky Medicaid 4% Rate Cut The administration expects the surplus funding to sustain current reimbursement levels through June 2027. NAAOP and OPGA Co-Host Second Annual In-Person Legislative Fly-In thumbnail NAAOP and OPGA Co-Host Second Annual In-Person Legislative Fly-In Last week, over 30 stakeholders, advocates, and leaders from around the O&P profession convened at the offices of Powers Pyles Sutter & Verville PC in Washington, D.C., as part of the National Association for the Advancement of Orthotics and Prosthetics' (NAAOP) second annual in-person legislative fly-in. Round 2028 Updates for Competitive Bidding & Interoperability Rule FAQ thumbnail Round 2028 Updates for Competitive Bidding & Interoperability Rule FAQ On Nov. 28, 2025, the Centers for Medicare & Medicaid Services (CMS) announced plans for Round 2028 of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (CBP). If you plan to bid, the time to prepare is now... What DMEPOS Providers Need to Know About H.R. 3514: Improving Seniors' Timely Access to Care Act thumbnail What DMEPOS Providers Need to Know About H.R. 3514: Improving Seniors' Timely Access to Care Act Medicare Advantage prior authorization continues to be one of the most significant operational and patient care challenges facing DMEPOS suppliers. A new bipartisan bill, H.R. 3514: Improving Seniors' Timely Access to Care Act, seeks to increase transparency, accountability, and oversight of Medicare Advantage prior authorization practices. This bill passed out of Ways & Means markup by a unanimous vote (42-0) on July 15... H.R. 1703 Advances, Bringing Greater Choice for Wheelchair Users thumbnail H.R. 1703 Advances, Bringing Greater Choice for Wheelchair Users The DMEPOS community, particularly wheelchair providers and users, should be celebrating an important victory as the House approved the Choices for Increased Mobility Act (H.R. 1703). North Carolina Medicaid Rate Floor Extended Through 2029 thumbnail North Carolina Medicaid Rate Floor Extended Through 2029 Earlier this year, it was announced that the North Carolina General Assembly has approved the state budget, securing an additional full two-year extension of the Medicaid fee schedule floor. This protection will now remain in effect until June 30, 2029, guaranteeing that reimbursement rates will continue to be set at 100% of the lesser of the supplier's usual and customary rate or the maximum allowable Medicaid fee-for-service rate. State Medicaid Work Requirements: The Impact on Medicaid beneficiaries and their DME Suppliers thumbnail State Medicaid Work Requirements: The Impact on Medicaid beneficiaries and their DME Suppliers Pursuant to the work and community engagement requirements included in H.R.1, the Centers for Medicare & Medicaid Services (CMS) has issued an interim final rule mandating a framework for Medicaid departments to follow when evaluating Medicaid beneficiary eligibility. Beginning no later than January 1, 2027, states must require certain adult Medicaid enrollees to demonstrate at least 80 hours per month of qualifying activity, which may include employment, education, or community...

Give your business an advantage over the competition.

Become a Member